Abera Bioscience AB (XSAT:ABERA) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:ABERA Abera Bioscience AB XSAT:ABERA
25 GF Score
Price kr8.22
! 1 Warning Sign
View Full Analysis

What is Abera Bioscience AB Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XSAT:ABERA
25GF Score
Abera Bioscience AB XSAT:ABERA
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abera Bioscience AB Business Description

Other Exchanges 8WK:Germany
Address Box 26029, Uppsala, SWE, 750 26
Abera Bioscience AB is a platform and vaccine development company based on research in the medical, molecular, and microbiological fields. The company's mission is to develop vaccine candidates based on its novel vaccine delivery platform to late pre-clinical or early clinical phase.
25GF Score

Get the complete analysis for XSAT:ABERA

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.22
Price